Before you sell to, join or invest in UBIVAC, INC.
MentionFox check on UBIVAC, INC.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/ubivac-inc-form-d-25000001
Check UBIVAC, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about UBIVAC, INC.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
UBIVAC, INC. filed a Form D with the Securities and Exchange Commission on 2025-03-11.
UBIVAC, INC. filed a Form D notice of an exempt securities offering with the SEC on March 11, 2025. The filing reports $35K sold. Its industry group is Biotechnology. It names Bernard Fox, Ph.D. (Executive Officer, Director), Hong-Ming Hu, Ph.D. (Executive Officer, Director), Bernard A. Fox, III (Executive Officer) (SEC Form D, March 11, 2025).
Is this your company?
Sell to companies like UBIVAC, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns UBIVAC, INC.
Free to see. No signup.
More on the people and the money behind UBIVAC, INC., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when UBIVAC, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when UBIVAC, INC. raises, hires or launches. No email unless you switch it on.
Watch UBIVAC, INC. →Get the full cited report on UBIVAC, INC.
What the filing shows about UBIVAC, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on UBIVAC, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives UBIVAC, INC.'s address as 18183 S.W. Boones Ferry Road, Portland, OR 97224.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for UBIVAC, INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
UBIVAC, INC. is a registered filer with the SEC (CIK 1713945) and has filed since 2023-11-08. 5 filings are on record, the latest on 2026-08-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
UBIVAC, INC.'s Form D of 2025-03-11 names Bernard Fox, Ph.D., Hong-Ming Hu, Ph.D., Bernard A. Fox, III and 1 more as its officers, directors or promoters.
Its new offerings report $265K sold across 4 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Proceeds may be used to pay normal executive compensation, the amount which cannot be estimated at this time.
Bernard Fox, Ph.D. is named as Executive Officer and Director on the Form D that UBIVAC, INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
Hong-Ming Hu, Ph.D. is named as Executive Officer and Director on the Form D that UBIVAC, INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
Bernard A. Fox, III is named as Executive Officer on the Form D that UBIVAC, INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
Sung Poblete, R.N., Ph.D. is named as Director on the Form D that UBIVAC, INC. filed with the SEC on 11 March 2025, one of 4 people that filing names.
4 people named on the filing — 3 holding an executive role and 1 as a director only.
Named as of the 2025-03-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about UBIVAC, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on UBIVAC, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on UBIVAC, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist UBIVAC, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind UBIVAC, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for UBIVAC, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Portland
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ubivac-inc-form-d-25000001